LISTA DE ATUALIZAÇÃO EM DOENÇA DE CHAGAS
Ano V n°164______04.10.2010
1. Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection.
Nagajyothi F, Zhao D, Machado FS, Weiss LM, Schwartz GJ, Desruisseaux MS, Zhao Y, Factor SM, Huang H, Albanese C, Teixeira MM, Scherer PE, Chua SC Jr, Tanowitz HB.
J Infect Dis. 2010 Oct 1;202(7):1104-13.
2. Interactions between intestinal compounds of triatomines and Trypanosoma cruzi.
Garcia ES, Genta FA, de Azambuja P, Schaub GA.
Trends Parasitol. 2010 Oct;26(10):499-505.
3. Determining the C-reactive protein level in patients with different clinical forms of chagas disease.
Aparecida da Silva C, Fattori A, Sousa AL, Mazon SB, Monte Alegre S, Almeida EA, Guariento ME.
Rev Esp Cardiol. 2010 Sep;63(9):1096-9. English, Spanish.
4. Infectivity, pathogenicity, and virulence of Trypanosoma cruzi Isolates from sylvatic animals and vectors, and domestic dogs from the United States in ICR strain mice and SD strain rats.
Roellig DM, Yabsley MJ.
Am J Trop Med Hyg. 2010 Sep;83(3):519-22.
5. In Vitro and in Vivo Trypanocidal Evaluation of Nickel Complexes with an Azapurine Derivative against Trypanosoma cruzi.
Maldonado CR, Marín C, Olmo F, Huertas O, Quirós M, Sánchez-Moreno M, Rosales MJ, Salas JM.
J Med Chem. 2010 Sep 2. [Epub ahead of print]
6. Antitrypanosomal agents: treatment or threat?
Issa VS, Bocchi EA.
Lancet. 2010 Sep 4;376(9743):768; author reply 768-9. No abstract available.
7. TOLERANCE OF BENZNIDAZOLE IN THE TREATMENT OF CHAGAS DISEASE IN ADULTS.
Pinazo MJ, Muñoz J, Posada E, López-Chejade P, Gállego M, Ayala E, Del Cacho E, Soy D, Gascon J.
Antimicrob Agents Chemother. 2010 Sep 7. [Epub ahead of print]
8. A Preformulation Study of a New Medicine for Chagas Disease Treatment: Physicochemical Characterization, Thermal Stability, and Compatibility of Benznidazole.
Soares-Sobrinho JL, de La Roca Soares MF, Lopes PQ, Correia LP, de Souza FS, Macêdo RO, Rolim-Neto PJ.
AAPS PharmSciTech. 2010 Sep 8. [Epub ahead of print]
9. Favorably orienting recombinant proteins to develop amperometric biosensors to diagnose Chagas' disease.
Belluzo MS, Ribone ME, Camussone C, Marcipar IS, Lagier CM.
Anal Biochem. 2010 Sep 7. [Epub ahead of print]
10. Evidence of Chagas disease in seronegative Brazilian patients with megaesophagus.
Batista AM, Aguiar C, Almeida EA, Guariento ME, Wanderley JS, Costa SC.
Int J Infect Dis. 2010 Sep 10. [Epub ahead of print]
11. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.
Junqueira C, Caetano B, Bartholomeu DC, Melo MB, Ropert C, Rodrigues MM, Gazzinelli RT.
Expert Rev Mol Med. 2010 Sep 15;12:e29.
12. Shed acute-phase antigen protein in an ELISA system for unequivocal diagnosis of congenital Chagas disease.
Russomando G, Sánchez Z, Meza G, de Guillen Y.
Expert Rev Mol Diagn. 2010 Sep;10(6):705-7. No abstract available.
13. Differentiation of Trypanosoma cruzi and Trypanosoma rangeli of Colombia using minicircle hybridization tests.
Botero A, Ortiz S, Muñoz S, Triana O, Solari A.
Diagn Microbiol Infect Dis. 2010 Sep 15. [Epub ahead of print]
14. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: Role of CD4(+) and CD8(+) T cells.
Limon-Flores AY, Cervera-Cetina R, Tzec-Arjona JL, Ek-Macias L, Sánchez-Burgos G, Ramirez-Sierra MJ, Cruz-Chan JV, Vanwynsberghe NR, Dumonteil E.
Vaccine. 2010 Sep 16. [Epub ahead of print]
15. Chagas disease and gynecologic neoplasias.
Dominical VM, Cavellani CL, Rocha LP, Corrêa RR, Pereira Gde A, Teixeira Vde P.
Ann Diagn Pathol. 2010 Oct;14(5):337-40.
16. High antitrypanosomal activity of plant-derived sulphur-containing amides.
Astelbauer F, Obwaller A, Raninger A, Brem B, Greger H, Duchêne M, Wernsdorfer W, Walochnik J.
Int J Antimicrob Agents. 2010 Sep 17. [Epub ahead of print]
17. In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
Chen YT, Brinen LS, Kerr ID, Hansell E, Doyle PS, McKerrow JH, Roush WR.
PLoS Negl Trop Dis. 2010 Sep 14;4(9). pii: e825.
18. [Seroprevalence of Chagas disease in Aguarico canton in the Ecuadorian Amazon]
Amunárriz M, Quito S, Tandazo V, López M.
Rev Panam Salud Publica. 2010 Jul;28(1):25-9. Spanish.
19. Western blotting method (TESAcruzi) as a supplemental test for confirming the presence of anti-Trypanosoma cruzi antibodies in finger prick blood samples from children aged 0-5 years in Brazil.
Frade AF, Luquetti AO, Prata A, Ferreira AW.
Acta Trop. 2010 Sep 19. [Epub ahead of print]
20. Congenital infections with Trypanosoma cruzi or Toxoplasma gondii are associated with decreased serum concentrations of interferon-γ and interleukin-18 but increased concentrations of interleukin-10.
Mayer JP, Biancardi M, Altcheh J, Freilij H, Weinke T, Liesenfeld O.
Ann Trop Med Parasitol. 2010 Sep;104(6):485-92.
21. Chagas Disease: 101 Years of Solitude! Time for Action.
Armaganijan L, Morillo CA.
Stroke. 2010 Sep 23. [Epub ahead of print] No abstract available.
22. Chagas Disease Predicts 10-Year Stroke Mortality in Community-Dwelling Elderly. The Bambui Cohort Study of Aging.
Lima-Costa MF, Matos DL, Ribeiro AL.
Stroke. 2010 Sep 23. [Epub ahead of print]
23. Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.
Bermejo DA, Amezcua Vesely MC, Khan M, Acosta Rodríguez EV, Montes CL, Merino MC, Toellner KM, Mohr E, Taylor D, Cunningham AF, Gruppi A.
Immunology. 2010 Sep 28. doi: 10.1111/j.1365-2567.2010.03347.x. [Epub ahead of print]
24. Chagas cardiomiopathy: the potential of diastolic dysfunction and brain natriuretic Peptide in the early identification of cardiac damage.
Garcia-Alvarez A, Sitges M, Pinazo MJ, Regueiro-Cueva A, Posada E, Poyatos S, Ortiz-Pérez JT, Heras M, Azqueta M, Gascon J, Sanz G.
PLoS Negl Trop Dis. 2010 Sep 21;4(9). pii: e826.
Atenciosamente,
Andreia Dantas
PIDC/Fiocruz
Tels.: 21-2562-1884/21-8811-1907
Homepages: www.fiocruz.br/pidc
www.fiocruz.br/chagas
www.fiocruz.br/chagas_esp
www.fiocruz.br/chagas_eng